A Supraphysiological dose of testosterone induces nitric oxide production and oxidative stress

European Journal of Preventive Cardiology

Volumn 21, Issue 8, 2014, Pages 1049-1054

  Skogastierna, Cristine ^a   Hotzen, Maja ^a   Rane, Anders ^a   Ekström, Lena ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anabolic androgenic steroids; endothelial dysfunction; NO; oxidative stress; Testosterone

Indexed keywords

ANABOLIC AGENT; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; MESSENGER RNA; METHYLTESTOSTERONE; NITRIC OXIDE; SELENOMETHIONINE; SUPEROXIDE DISMUTASE; TESTOSTERONE ENANTATE; METHIONINE; METHIONINE SELENOXIDE; ORGANOSELENIUM DERIVATIVE; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ABUSE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE DRUG DOSE; VASCULAR ENDOTHELIUM; ADOLESCENT; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; URINE;

ADOLESCENT; ADULT; ENDOTHELIAL CELLS; GENE EXPRESSION; HEALTHY VOLUNTEERS; HUMANS; IN VITRO TECHNIQUES; MALE; METHIONINE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ORGANOSELENIUM COMPOUNDS; OXIDATIVE STRESS; RNA, MESSENGER; TESTOSTERONE;

EID: 84904873660     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313481755     Document Type: Article

References (26)

1. Eklof AC, Thurelius AM, Garle M, et al. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003 ; 59: 571-577 (Pubitemid 37494522)
2. Kanayama G, Brower KJ, Wood RI, et al. Anabolic-androgenic steroid dependence: An emerging disorder. Addiction. 2009 ; 104: 1966-1978
3. Sjoqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008 ; 371: 1872-1882 (Pubitemid 351734542)
4. McKillop G, Todd IC, Ballantyne D. Increased left ventricular mass in a bodybuilder using anabolic steroids. Br J Sports Med. 1986 ; 20: 151-152
5. Campbell SE, Farb A, Weber KT. Pathologic remodeling of the myocardium in a weightlifter taking anabolic steroids. Blood Press. 1993 ; 2: 213-216 (Pubitemid 23308903)
6. Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol. 2010 ; 195: 411-457
7. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 ; 340: 1111-1115
8. Ebenbichler CF, Sturm W, Ganzer H, et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis. 2001 ; 158: 483-490 (Pubitemid 32913661)
9. D'Ascenzo S, Millimaggi D, Di Massimo C, et al. Detrimental effects of anabolic steroids on human endothelial cells. Toxicol Lett. 2007 ; 169: 129-136 (Pubitemid 46275317)
10. Mitchell JA, Ali F, Bailey L, et al. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exper Physiol. 2008 ; 93: 141-147 (Pubitemid 350293980)
11. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998 ; 101: 2567-2578 (Pubitemid 28270451)
12. Tai SC, Robb GB, Marsden PA. Endothelial nitric oxide synthase: A new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol. 2004 ; 24: 405-412 (Pubitemid 38326131)
13. Gori T, Munzel T. Oxidative stress and endothelial dysfunction: Therapeutic implications. Ann Med. 2011 ; 43: 259-272
14. Schulze JJ, Lundmark J, Garle M, et al. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab. 2008 ; 93: 2500-2506 (Pubitemid 352008513)
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 ; 25: 402-408 (Pubitemid 34164012)
16. Goglia L, Tosi V, Sanchez AM, et al. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo. Mol Hum Reprod 16: 761-769.
17. Pey A, Saborido A, Blazquez I, et al. Effects of prolonged stanozolol treatment on antioxidant enzyme activities, oxidative stress markers, and heat shock protein HSP72 levels in rat liver. J Steroid Biochem Mol Biol. 2003 ; 87: 269-277 (Pubitemid 38036962)
18. Bonetti A, Tirelli F, Catapano A, et al. Side effects of anabolic androgenic steroids abuse. Int J Sports Med. 2008 ; 29: 679-687
19. Severo CB, Ribeiro JP, Umpierre D, et al. Increased atherothrombotic markers and endothelial dysfunction in steroid users. Euro J Prev Cardiol 2013; 20: 195-201.
20. Ekstrom L, Schulze JJ, Guillemette C, et al. Bioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5?-diphospho-glucuronosyltransferase (UGT2B17) gene. Pharmacogenet Genomics. 2011 ; 21: 325-332
21. Simon D, Nahoul K, Charles MA Androgens and the aging male. New York: Parthenon Publishing ; 1996:
22. Empen K, Lorbeer R, Dorr M, et al. Association of testosterone levels with endothelial function in men: Results from a population-based study. Arterioscler Thromb Vasc Biol. 2012 ; 32: 481-486
23. Haring R, Volzke H, Spielhagen C, et al. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome. Euro J Prev Cardiol 2013; 20: 1061-1068.
24. Francomano D, Bruzziches R, Natali M, et al. Cardiovascular effect of testosterone replacement therapy in aging male. Acta Biomed. 2010 ; 81: 101-106
25. Shen W, Zhang X, Zhao G, et al. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc. 1995 ; 27: 1125-1134
26. Sung HJ, Yee A, Eskin SG, et al. Cyclic strain and motion control produce opposite oxidative responses in two human endothelial cell types. Am J Physiol Cell Physiol. 2007 ; 293: C87 - C94